CagriSema is a combination of cagrilintide and semaglutide, which leverages the benefits of both a long-acting amylin analog and a GLP-1 receptor agonist to enhance weight loss, potentially offering a dual mechanism of action that current treatments don't provide
If GLP-1 receptor agonists do influence rheumatoid arthritis, the mechanisms would likely involve both direct immunomodulatory effects and indirect benefits through metabolic improvement
Sermorelin plus Ipamorelin prove quite safe to use but come with a few side effects
Borowczyk, K., Olejarz, P., Chwatko, G., Szylberg, M
One such side effect gaining attention is hair loss, prompting many to wonder about the connection between GLP-1 medications and hair health